<DOC>
	<DOCNO>NCT01388660</DOCNO>
	<brief_summary>This randomize , open-label , single-dose , two-sequence , two-period crossover study investigate pharmacokinetics tablet contain 75 mg Clopidogrel 100 mg Aspirin simultaneous administration separate formulation two drug healthy male volunteer .</brief_summary>
	<brief_title>Pharmacokinetic Assessment Simultaneous Administration Clopidogrel Aspirin</brief_title>
	<detailed_description>Eligibility participation study determine demographic information , medical history , physical examination , electrocardiogram ( ECG ) clinical laboratory test within 4 week study drug administration . Subjects suitable study admit Clinical Trial Center Ajou Medical Center day dose , overnight-fasted 10 p.m. Day -1 . Subjects dose study drug ( tablet contain 75 mg Clopidogrel 100 mg Aspirin , simultaneous administration separate formulation two drug ) orally 240 mL water around 8 a.m. Day 1 . Subjects perform schedule pharmacokinetic sample upto 24 hour . After 2 week washout period , Subjects dose study drug crossover manner , perform schedule pharmacokinetic sample upto 24 hour . Study participation end post-study visit ( Day 25 ) .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Platelet Aggregation Inhibitors</mesh_term>
	<criteria>Healthy male subject age 20 45 year With 20 % ideal body weight , { Ideal body weight= [ height ( cm ) 100 ] *0.9 } Agreement write informed consent Clinically significant cardiovascular , pulmonary , hepatic , renal , hematologic , gastrointestinal disease mental disorder ( Past history present ) Subject symptom acute disease within 28 day start administration investigational drug Subject know history affect ADME drug Clinically significant active chronic disease Inadequate result laboratory test ( especially , Platelet count &lt; 150,000 , Platelet count &gt; 350,000 , AST/ALT &gt; 1.25 x UNL , Total bilirubin &gt; 1.5 x UNL ) Positive reaction HBs Ag , antiHCV Ab , antiHIV Ab , VDRL test Taking OTC ( Over counter ) medicine include oriental medicine within 7 day Clinically significant allergic disease ( Except mild allergic rhinitis dermatitis seem need medication ) Subject know hypersensitivity reaction clopidogrel aspirin analog Not able take institutional standard meal Previously make whole blood donation within 60 day component blood donation within 30 day Previously participate trial within 90 day Continued take caffeine ( caffeine &gt; 5 cup/day ) , drink ( alcohol &gt; 30 g/day ) severe heavy smoker ( cigarette &gt; 1/2 pack per day ) An impossible one participate clinical trial investigator 's decision include reason laboratory test result</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>Healthy</keyword>
	<keyword>Platelet Aggregation Inhibitors</keyword>
	<keyword>Pharmacokinetics</keyword>
</DOC>